While OnKure Therapeutics Inc has underperformed by -5.64%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OKUR fell by -90.11%, with highs and lows ranging from $20.00 to $1.83, whereas the simple moving average fell by -82.19% in the last 200 days.
On April 30, 2025, Evercore ISI started tracking OnKure Therapeutics Inc (NASDAQ: OKUR) recommending Outperform. A report published by Leerink Partners on December 05, 2024, Initiated its previous ‘Outperform’ rating for OKUR. Oppenheimer also rated OKUR shares as ‘Outperform’, setting a target price of $35 on the company’s shares in an initiating report dated October 10, 2024. Jefferies December 15, 2023d its ‘Buy’ rating to ‘Hold’ for OKUR, as published in its report on December 15, 2023. H.C. Wainwright’s report from December 15, 2023 suggests a price prediction of $1.50 for OKUR shares, giving the stock a ‘Neutral’ rating. William Blair also rated the stock as ‘Mkt Perform’.
Analysis of OnKure Therapeutics Inc (OKUR)
OnKure Therapeutics Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -70.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 11.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can be an extremely valuable indicator of volatility, and OKUR is registering an average volume of 55.34K. On a monthly basis, the volatility of the stock is set at 9.24%, whereas on a weekly basis, it is put at 12.98%, with a loss of -17.49% over the past seven days. Furthermore, long-term investors anticipate a median target price of $32.00, showing growth from the present price of $1.84, which can serve as yet another indication of whether OKUR is worth investing in or should be passed over.
How Do You Analyze OnKure Therapeutics Inc Shares?
Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 36.32%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 61.70% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
OKUR shares are owned by institutional investors to the tune of 61.70% at present.
